117 related articles for article (PubMed ID: 2826918)
1. Cytosol type II sites in the rat uterus: interaction with an endogenous ligand.
Markaverich BM; Adams NR; Roberts RR; Alejandro M; Clark JH
J Steroid Biochem; 1987 Dec; 28(6):599-608. PubMed ID: 2826918
[TBL] [Abstract][Full Text] [Related]
2. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
Markaverich BM; Williams M; Upchurch S; Clark JH
Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
[TBL] [Abstract][Full Text] [Related]
4. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
[TBL] [Abstract][Full Text] [Related]
5. Preliminary characterization of an endogenous inhibitor of [3H]estradiol binding in rat uterine nuclei.
Markaverich BM; Roberts RR; Finney RW; Clark JH
J Biol Chem; 1983 Oct; 258(19):11663-71. PubMed ID: 6619136
[TBL] [Abstract][Full Text] [Related]
6. An endogenous ligand for type II binding sites in normal and neoplastic tissues.
Clark JH; Markaverich BM
Adv Exp Med Biol; 1986; 196():305-15. PubMed ID: 3716924
[TBL] [Abstract][Full Text] [Related]
7. Estradiol and tamoxifen interaction at receptor sites at 37 C.
Fishman JH
Endocrinology; 1983 Sep; 113(3):1164-6. PubMed ID: 6191968
[TBL] [Abstract][Full Text] [Related]
8. Uterine type II estrogen-binding sites are not of eosinophil origin.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
J Biol Chem; 1986 Jan; 261(1):142-6. PubMed ID: 3941067
[TBL] [Abstract][Full Text] [Related]
9. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition.
Markaverich BM; Roberts RR; Alejandro MA; Johnson GA; Middleditch BS; Clark JH
J Steroid Biochem; 1988; 30(1-6):71-8. PubMed ID: 3386279
[TBL] [Abstract][Full Text] [Related]
10. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
Markaverich BM; Roberts RR; Alejandro M; Clark JH
Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor.
Jasper TW; Ruh MF; Ruh TS
J Steroid Biochem; 1985 Nov; 23(5A):537-45. PubMed ID: 4079371
[TBL] [Abstract][Full Text] [Related]
12. Effects of salt extraction on the quantitation of nuclear estrogen receptors: interference by secondary estrogen binding sites.
Markaverich BM; Upchurch S; Clark JH
J Recept Res; 1980; 1(3):415-38. PubMed ID: 7299739
[TBL] [Abstract][Full Text] [Related]
13. Rapid recovery of nuclear estrogen receptor and oxytocin receptor in the ovine uterus following progesterone withdrawal.
Leavitt WW; Okulicz WC; McCracken JA; Schramm W; Robidoux WF
J Steroid Biochem; 1985 Jun; 22(6):687-91. PubMed ID: 2991657
[TBL] [Abstract][Full Text] [Related]
14. Type I estrogen receptors cannot be histochemically localized in frozen tissue sections using estradiol-albumin-FITC conjugates.
Binder M; Böhm M; Halbritter H
Acta Histochem Suppl; 1984; 29():71-7. PubMed ID: 6425928
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of [3H]estradiol binding sites in the rat prostate: properties and distribution of type I and type II sites.
Yu M; Cates J; Leav I; Ho SM
J Steroid Biochem; 1989 Sep; 33(3):449-57. PubMed ID: 2779236
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.
Katzenellenbogen BS; Ferguson ER
Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821
[TBL] [Abstract][Full Text] [Related]
17. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
Ruh TS; Baudendistel LJ
Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
[TBL] [Abstract][Full Text] [Related]
18. Progesterone decreases the concentration of hypothalamic and anterior pituitary estrogen receptors in ovariectomized rats.
Blaustein JD; Brown TJ
Brain Res; 1984 Jun; 304(2):225-36. PubMed ID: 6744041
[TBL] [Abstract][Full Text] [Related]
19. Characterization and partial purification of an estrogen type II binding site in chick oviduct cytosol.
Densmore CL; Markaverich BM; O'Malley BW; Clark JH
Biochemistry; 1989 Sep; 28(19):7788-96. PubMed ID: 2611214
[TBL] [Abstract][Full Text] [Related]
20. Effects of chlorpromazine on the inhibition and artifactual elevation of [3H]estradiol binding to estrogen receptors in rat uterine cytosol.
Campbell PS; Clark JH
J Steroid Biochem; 1984 Oct; 21(4):475-6. PubMed ID: 6387281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
